FR2353M - Nouveaux esters aminoalkyliques de l'hydroxy-3beta-pregnene-5-one-20 utiles comme médicaments de l'épilepsie. - Google Patents

Nouveaux esters aminoalkyliques de l'hydroxy-3beta-pregnene-5-one-20 utiles comme médicaments de l'épilepsie.

Info

Publication number
FR2353M
FR2353M FR905983A FR905983A FR2353M FR 2353 M FR2353 M FR 2353M FR 905983 A FR905983 A FR 905983A FR 905983 A FR905983 A FR 905983A FR 2353 M FR2353 M FR 2353M
Authority
FR
France
Prior art keywords
pregnene
3beta
epilepsy
drugs
hydroxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR905983A
Other languages
English (en)
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GD Searle LLC
Original Assignee
GD Searle LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GD Searle LLC filed Critical GD Searle LLC
Application granted granted Critical
Publication of FR2353M publication Critical patent/FR2353M/fr
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of only two carbon atoms, e.g. pregnane derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
    • C07J7/002—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa not substituted in position 16

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Steroid Compounds (AREA)
FR905983A 1961-08-17 1962-08-03 Nouveaux esters aminoalkyliques de l'hydroxy-3beta-pregnene-5-one-20 utiles comme médicaments de l'épilepsie. Active FR2353M (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13200361A 1961-08-17 1961-08-17

Publications (1)

Publication Number Publication Date
FR2353M true FR2353M (fr) 1964-02-24

Family

ID=22451986

Family Applications (1)

Application Number Title Priority Date Filing Date
FR905983A Active FR2353M (fr) 1961-08-17 1962-08-03 Nouveaux esters aminoalkyliques de l'hydroxy-3beta-pregnene-5-one-20 utiles comme médicaments de l'épilepsie.

Country Status (3)

Country Link
BE (1) BE621470A (cs)
FR (1) FR2353M (cs)
GB (1) GB966060A (cs)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987007895A1 (en) * 1986-06-23 1987-12-30 The Upjohn Company Androstane-type and cortical aminoesters
TWI389917B (zh) 2006-04-13 2013-03-21 Sigma Tau Ind Farmaceuti 作為心血管疾病治療藥物的雄甾烷與雄甾烯之氮雜環烷基衍生物

Also Published As

Publication number Publication date
GB966060A (en) 1964-08-06
BE621470A (cs)

Similar Documents

Publication Publication Date Title
BE612901A (fr) Procédé de préparation d'orthoalcoylphénols
FR1374746A (fr) Procédé pour la préparation d'esters d'acide ascorbique, ainsi que leur utilisation
CH409952A (fr) Procédé de préparation d'esters de pseudosapogénines
FR2589M (fr) Esters basiques d'acides 1-benzoxa-cycloalkanecarboxyliques.
FR2353M (fr) Nouveaux esters aminoalkyliques de l'hydroxy-3beta-pregnene-5-one-20 utiles comme médicaments de l'épilepsie.
BE612470A (fr) Procédé de raffinage de l'amyloglucosidase
AT241468B (de) Verfahren zur Herstellung von neuen 1, 4-Bis- {[7'-chlorchinolyl-(4')]-aminoalkyl }-piperazinen
FR1494701A (fr) Nouveaux esters-amides dérivés de l'acide n-heptanoïque, et leur utilisation comme plastifiants
FR93252E (fr) Procédé de préparation d'haloalcoyl-thiazols.
FR1299760A (fr) Procédé de raffinage de l'amyloglucosidase
BE608801A (fr) Procédé de préparation d'esters dithiophosphoriques.
FR3028M (fr) Nouveaux médicaments constitués par des esters basiques de l'acide 3,5-diméthoxy-4-alkoxybenzoique.
BE596287A (fr) Procédé de préparation d'O-alcoyl-hydroxylamines.
BE587137A (fr) Procédé de préparation d'amides aromatiques ortho-disubstituées.
FR79944E (fr) Procédé de préparation de l'ester fluoro-3 cétobutyrolactone-carboxylique et de l'ester alpha-fluoracrylique
FR1318489A (fr) Procédé de préparation d'hydroxy-aldéhydes
FR1294134A (fr) Procédé de préparation d'alpha-lipoamides
CH402856A (fr) Procédé de préparation d'acétylacétonate manganeux
BE615452A (fr) Nouveaux médicaments dérivés de l'oxazolidinone-2
BE618999A (fr) Procédé de préparation d'esters acryliques.
BE623148A (fr) Procédé de préparation d'haloalcoylthiazols.
BE619299A (fr) Préparation d'esters à partir de méthylacétylène.
FR1435M (fr) Nouveaux médicaments dérivés de l'acide méthyl-3 pentene-4 oique.
BE599068A (fr) Procédé de préparation de nouveaux esters de la série de l'androstane.
BE597411A (fr) Compositions pharmaceutiques destinées au traitement de l'épilepsie.